Nuovo Ospedale di Prato-S.Stefano

Prato 59100

2 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, COVID-19, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Receptors, Fibroblast Growth Factor, Urothelial Cancer

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer — Recruiting now
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed